CUSIP 019770106COMALLOQ4 2025
52 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Pfizer Inc | 22.03M | $30.18M |
| 2 | Tpg Gp A, LLC | 18.72M | $25.64M |
| 3 | Blackrock, Inc. | 17.68M | $24.22M |
| 4 | Citadel Advisors LLC | 12.11M | $16.59M |
| 5 | Vanguard Group Inc | 9.25M | $12.67M |
| 6 | Primecap Management Co/Ca/ | 8.14M | $11.15M |
| 7 | Patient Square Capital LP | 4.96M | $6.80M |
| 8 | Geode Capital Management, LLC | 3.93M | $5.39M |
| 9 | Frazier Life Sciences Management, L.P. |
| 4 | Nov 13, 2025 | Capital World Investors | 13G/A | — | — | SEC |
| 5 | Nov 13, 2025 | Arie Belldegrun, M.D. | 13G/A | 5.6% | 12.67M | SEC |
| 6 | Nov 12, 2025 | David D. Chang, M.D., Ph.D. | 13G/A | 4.9% | 11.23M | SEC |
| 7 | Aug 12, 2025 | Arie Belldegrun, M.D. | 13G/A | 5.7% | 12.61M | SEC |
| 8 | Aug 8, 2025 | David D. Chang, M.D., Ph.D. | 13G/A | 5.0% | 11.14M | SEC |
| 9 | Jul 16, 2025 | Citadel Advisors LLC | 13G | 6.1% | 13.35M | SEC |
| 10 | May 13, 2025 | Capital World Investors | 13G | 5.6% | 12.27M | SEC |
See the full Schedule 13D/13G history for Allogene Therapeutics Inc.
Unlock full history| 3.87M |
| $5.30M |
| 10 | Woodline Partners LP | 3.50M | $4.80M |